Literature DB >> 33741808

Telerheumatology: before, during, and after a global pandemic.

Rachel A Matsumoto1, Jennifer L Barton1,2.   

Abstract

PURPOSE OF REVIEW: In early 2020, the COVID-19 global pandemic shifted most healthcare to remote delivery methods to protect patients, clinicians, and hospital staff. Such remote care delivery methods include the use of telehealth technologies including clinical video telehealth or telephone visits. Prior to this, research on the acceptability, feasibility, and efficacy of telehealth applied to rheumatology, or telerheumatology, has been limited. RECENT
FINDINGS: Telerheumatology visits were found to be noninferior to in-person visits and are often more time and cost effective for patients. Clinicians and patients both noted the lack of a physical exam in telehealth visits and patients missed the opportunity to have lab work done or other diagnostic tests they are afforded with in-person visits. Overall, patients and clinicians had positive attitudes toward the use of telerheumatology and agreed on its usefulness, even beyond the pandemic.
SUMMARY: Although telerheumatology has the potential to expand the reach of rheumatology practice, some of the most vulnerable patients still lack the most basic resources required for a telehealth visit. As the literature on telerheumatology continues to expand, attention should be paid to health equity, the digital divide, as well as patient preferences in order to foster true shared decision-making over telehealth.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33741808     DOI: 10.1097/BOR.0000000000000790

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

1.  Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey.

Authors:  Eugenia Yupei Chock; Michael Putman; Richard Conway; Maria I Danila; Bimba Hoyer; Evelyn Hsieh; Arundathi Jayatilleke; Adam Kilian; Jan Leipe; Jean W Liew; Pedro M Machado; Philip C Robinson; Namrata Singh; Natasha Ung; Su-Ann Yeoh; Zachary S Wallace; Rebecca Grainger; Laura C Cappelli
Journal:  Rheumatol Adv Pract       Date:  2022-05-12

Review 2.  Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era.

Authors:  Stefan Schreiber; Shomron Ben-Horin; Rieke Alten; René Westhovens; Laurent Peyrin-Biroulet; Silvio Danese; Toshifumi Hibi; Ken Takeuchi; Fernando Magro; Yoorim An; Dong-Hyeon Kim; SangWook Yoon; Walter Reinisch
Journal:  Adv Ther       Date:  2022-01-06       Impact factor: 4.070

Review 3.  The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life.

Authors:  Khadija El Aoufy; Maria Ramona Melis; Silvia Bellando Randone; Jelena Blagojevic; Francesca Bartoli; Ginevra Fiori; Francesca Nacci; Maria Letizia Conforti; Laura Cometi; Cosimo Bruni; Martina Orlandi; Alberto Moggi-Pignone; Laura Rasero; Serena Guiducci; Marco Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2021-11-05       Impact factor: 2.980

4.  Patients' perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey.

Authors:  Hannah Jethwa; Melanie Brooke; Andrew Parkinson; Emma Dures; Nicola J Gullick
Journal:  BMC Rheumatol       Date:  2022-02-22

5.  The Use of Telehealth for Psychological Counselling of Vulnerable Adult Patients With Rheumatic Diseases or Diabetes: Explorative Study Inspired by Participatory Design.

Authors:  Mette Juel Rothmann; Julie Drotner Mouritsen; Nanna Skov Ladefoged; Marie Nedergaard Jeppesen; Anna Sofie Lillevang; Helle Laustrup; Torkell Ellingsen
Journal:  JMIR Hum Factors       Date:  2022-03-21

6.  Telehealth Made EASY: Understanding Provider Perceptions of Telehealth Appropriateness in Outpatient Rheumatology Encounters.

Authors:  Isaac D Smith; Theresa M Coles; Catherine Howe; Robert Overton; Nicoleta Economou-Zavlanos; Mary J Solomon; Rong Zhao; Bhargav Adagarla; Jayanth Doss; Ricardo Henao; Megan E B Clowse; David L Leverenz
Journal:  ACR Open Rheumatol       Date:  2022-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.